Flovent HFA and Flovent Diskus are inhaled corticosteroid medicines used as a controller medicine to treat asthma. Flovent HFA is also used to treat eosinophilic esophagitis (EoE). Glaxo Smith Kline (GSK), the manufacturer of Flovent, discontinued production of Flovent HFA and Flovent Diskus as of December 31st, 2023. As part of this process, GSK is making an “authorized generic” which is the exact same medicine with the same dosing but without the branding. To learn more or to find answers to some frequently asked questions click here.
Michigan Medicaid’s Common Formulary responds to Flovent discontinuation:
To read the complete response, click here.
INHALE CQI: MICMT and INHALE are partnering to provide this service to practices and POs participating in the INHALE CQI. Nada serves on the INHALE education workgroup and can help provide resources specific to your practice site. General educational resources related to INHALE are available to all practices (regardless of participation in the CQI) at INHALE Resources.
Details: Slots are 30 minutes long and there is a maximum of 2 slots per month. Prior to your session, please complete the following form as well: Consult Questionnaire.
If you’re interested in a consultation with our partner pharmacist, sign up here.
To assist providers in finding covered medications for their patients, a free Coverage Search app is available for download in the Apple and Google app stores. The app includes access to accurate and timely formulary status at your fingertips. Learn more about the app and it’s features here.